Pilocarpine treatment of xerostomia induced by psychoactive medications [7]

American Journal of Psychiatry

Volumn 162, Issue 5, 2005, Pages 1023-

  Masters, Kim J ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

BENZATROPINE; CHOLINERGIC RECEPTOR BLOCKING AGENT; CLOZAPINE; MIRTAZAPINE; OLANZAPINE; PILOCARPINE; PSYCHOTROPIC AGENT; TRICYCLIC ANTIDEPRESSANT AGENT;

ANTICHOLINERGIC EFFECT; CLINICAL TRIAL; CLOSED ANGLE GLAUCOMA; DENTAL CARIES; DIAPHORESIS; DRUG CONTRAINDICATION; HUMAN; INFECTION RISK; LETTER; MOUTH INFECTION; PRIORITY JOURNAL; SIDE EFFECT; SWEATING; URINARY FREQUENCY; XEROSTOMIA;

ADULT; AGED; HUMANS; MENTAL DISORDERS; MIDDLE AGED; MUSCARINIC AGONISTS; PILOCARPINE; PSYCHOTROPIC DRUGS; XEROSTOMIA;

EID: 21044444842     PISSN: 0002953X     EISSN: None     Source Type: Journal    
DOI: 10.1176/appi.ajp.162.5.1023     Document Type: Letter

References (4)

1. Haddad P, Kanimi M: A randomized double-blind, placebo controlled trial of concomitant pilocarpine with head and neck irradiation for prevention of radiation-induced xerostomia. Radiother Oncol 2002; 64:29-32
2. Papas AS, Sherrer YS, Charney M, Golden HE, Medsger TA, Walsh DO, Trivedi M, Goldlust B, Gallagher SC: Successful treatment of dry mouth and dry eye symptoms in Sjogren's syndrome patients with oral pilocarpine. J Clin Rheumatol 2004; 10:169-177
3. Gotrick B, Akerman S, Erickson D, Torstenson R, Tobin G: Oral pilocarpine for treatment of opioid-induced dryness in healthy adults. J Dent Res 2004; 83:393-397
4. Hendrickson RG, Morocco AP, Greenberg MI: Pilocarpine toxicity and the treatment of xerostomia. J Emerg Med 2004; 26: 429-432